Veracyte | VCYT - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agenus USD 35M 32M 2026-03
Agilent USD 1.76B 31M 2025-12
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Bruker USD 133.4M 165.4M 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Illumina USD 1.42B 368M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Laboratory Of America USD 981.1M 448.8M 2026-03
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
Myriad Genetics USD 124.4M 25.2M 2026-03
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Siemens EUR 15.26B 768M 2025-12
Sonic Healthcare AUD 645M 25.39M 2024-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 263.14M 99.44M 2026-03
Waters USD 462M 125.83M 2026-03